AMGEVITA
AMGEVITA
Approved
DIN Number
02459299
Drug Class
Human
Market Date
Feb 19, 2021
Company
HC
Amgen Canada Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02459299
AIG Number0150364003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
L04AB04 ADALIMUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification90:24.16.92
Health Canada Classification
ACTIVE INGREDIENTS (1)
ADALIMUMABActive
Strength: 50 MG / ML
Monograph: ADALIMUMAB